Spotlighting Champions of Change: Meetings with Rep. Blake Moore and Sen. Patty Murray's Staff

Published in Government Relations on October 28, 2024

We are proud to recognize two HME suppliers and VGM members who have recently taken the initiative to engage with their legislators and staff members. 

Moore

Rep. Blake Moore (center) with Alpine Medical in Ogden, UT

Alpine Home Medical hosted Rep. Blake Moore (R-UT) at their Ogden, UT location last week. CEO Jay Broadbent reported that Rep. Moore was highly informed and supportive of DMEPOS legislation. As a member of the House Ways and Means Committee, Rep. Moore is already a co-sponsor of H.R. 5555. 

Olympic

Sen. Patty Murray's staff (center) with Olympic Pharmacy in Gig Harbor, WA

Olympic Pharmacy in Gig Harbor, WA, welcomed Juan Beltran-Gonzalez, a staff member of Sen. Patty Murray (D-WA), for a facility tour and discussion of DMEPOS legislation, S. 1294. Sen. Murray plays a crucial role in healthcare legislation, serving on both the Senate Health, Education, Labor, and Pensions (HELP) Committee and the Senate Appropriations Committee. 

These events exemplify how HME suppliers can effectively educate their legislators on DMEPOS issues and become champions of change. This grassroots advocacy is essential for the passage of DMEPOS legislation, and we encourage all HME suppliers to engage with their legislators to garner the necessary support. 

How to Gain Legislative Support for DMEPOS Legislation 

Engaging with your legislators is crucial for gaining support for DMEPOS legislation. Here are some effective strategies: 

Invite them to your office: Offer a tour and arrange a meeting to discuss the importance of DMEPOS legislation. 

Request an in-person meeting: Schedule a visit to their office to present your case directly. 

Attend public events: Approach them at state or town fairs and discuss the issues face-to-face. 

Reach out to their staff: Contact their staff members to request their support. 

The period after elections but before the new administration takes over, known as the “lame duck” period, is a unique opportunity. Outgoing politicians can make decisions with little fear of consequence, making it an ideal time to seek additional support for DMEPOS legislation. We are optimistic that an end-of-the-year package will include the DMEPOS bill. 

For assistance in connecting with your legislator, please contact Emily Harken at Emily.Harken@vgm.com. 


TAGS

  1. hme
  2. vgm government

From Our Experts

Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers.